共有 50 笔近期内部人交易记录记录，涉及 Structure Therapeutics Inc. (GPCR), 包括 28 笔买入 和 22 笔卖出. 内部人买入总额为 $22.67M 内部人卖出总额为 $3.19M.
近期活跃的重要内部人包括 Stevens Raymond C, Hall Ashley, Yoon Jun. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — GPCR
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-19 |
Stevens Raymond C |
Chief Executive Officer |
限制性股票授予 (RSU) |
322,230 |
$16.82 |
$5.42M |
322,230 |
| 2026-03-19 |
Hall Ashley |
Chief Development Officer |
限制性股票授予 (RSU) |
59,073 |
$16.82 |
$993.61K |
59,073 |
| 2026-03-19 |
Yoon Jun |
Chief Financial Officer |
限制性股票授予 (RSU) |
128,892 |
$16.82 |
$2.17M |
128,892 |
| 2026-03-19 |
Lin Xichen |
Chief Scientific Officer |
限制性股票授予 (RSU) |
53,703 |
$16.82 |
$903.28K |
53,703 |
| 2026-03-19 |
Ma Yingli |
Chief Technology Officer |
限制性股票授予 (RSU) |
40,278 |
$16.82 |
$677.48K |
40,278 |
| 2026-03-19 |
Coll Crespo Blas |
Chief Medical Officer |
限制性股票授予 (RSU) |
93,984 |
$16.82 |
$1.58M |
93,984 |
| 2026-03-03 |
Stevens Raymond C |
Chief Executive Officer |
RSU 预扣税 |
53,454 |
$20.99 |
$1.12M |
1,141,376 |
| 2026-03-03 |
Hall Ashley |
Chief Development Officer |
RSU 预扣税 |
4,836 |
$20.99 |
$101.51K |
107,481 |
| 2026-03-03 |
Yoon Jun |
Chief Financial Officer |
RSU 预扣税 |
22,305 |
$20.99 |
$468.18K |
1,297,571 |
| 2026-03-03 |
Lin Xichen |
Chief Scientific Officer |
RSU 预扣税 |
18,735 |
$20.99 |
$393.25K |
185,592 |
| 2026-03-03 |
Ma Yingli |
Chief Technology Officer |
RSU 预扣税 |
11,313 |
$20.99 |
$237.46K |
107,391 |
| 2026-03-03 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 预扣税 |
11,826 |
$20.99 |
$248.23K |
204,981 |
| 2026-01-15 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
知情卖出 |
20 |
- |
- |
4,103 |
| 2025-12-08 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
知情卖出 |
15,535 |
- |
- |
- |
| 2025-11-20 |
Stevens Raymond C |
Chief Executive Officer |
限制性股票授予 (RSU) |
824 |
- |
- |
1,824 |
| 2025-11-20 |
Hall Ashley |
Chief Development Officer |
限制性股票授予 (RSU) |
237 |
- |
- |
462 |
| 2025-09-18 |
Hall Ashley |
Chief Development Officer |
RSU 预扣税 |
6,021 |
$7.74 |
$46.62K |
112,317 |
| 2025-09-18 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 预扣税 |
8,106 |
$7.74 |
$62.77K |
216,807 |
| 2025-07-30 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
知情卖出 |
26,310 |
- |
- |
1,515,558 |
| 2025-07-01 |
Lin Xichen |
Chief Scientific Officer |
RSU 预扣税 |
12,846 |
$6.84 |
$87.82K |
204,327 |
| 2025-07-01 |
Ma Yingli |
Chief Technology Officer |
RSU 预扣税 |
4,470 |
$6.84 |
$30.56K |
118,704 |
| 2025-07-01 |
Stevens Raymond C |
Chief Executive Officer |
RSU 预扣税 |
16,050 |
$6.84 |
$109.73K |
1,194,830 |
| 2025-07-01 |
Yoon Jun |
Chief Financial Officer |
RSU 预扣税 |
7,089 |
$6.84 |
$48.46K |
1,319,876 |
| 2025-07-01 |
Lin Xichen |
Chief Scientific Officer |
限制性股票授予 (RSU) |
57,078 |
- |
- |
217,173 |
| 2025-07-01 |
Ma Yingli |
Chief Technology Officer |
限制性股票授予 (RSU) |
24,459 |
- |
- |
123,174 |
| 2025-07-01 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 预扣税 |
1,434 |
$6.84 |
$9.8K |
224,913 |
| 2025-06-23 |
Love Ted W |
Director |
限制性股票授予 (RSU) |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Dobmeier Eric |
Director |
限制性股票授予 (RSU) |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Welch Daniel G |
Director |
限制性股票授予 (RSU) |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Tetlow Sharon |
Director |
限制性股票授予 (RSU) |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Russell Angus C. |
Director |
限制性股票授予 (RSU) |
42,833 |
$7.37 |
$315.68K |
42,833 |
| 2025-06-23 |
Waldstreicher Joanne |
Director |
限制性股票授予 (RSU) |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-05-21 |
Stevens Raymond C |
Chief Executive Officer |
限制性股票授予 (RSU) |
1,000 |
- |
- |
1,000 |
| 2025-05-21 |
Yoon Jun |
Chief Financial Officer |
限制性股票授予 (RSU) |
831 |
- |
- |
2,946 |
| 2025-05-21 |
Coll Crespo Blas |
Chief Medical Officer |
限制性股票授予 (RSU) |
429 |
- |
- |
1,157 |
| 2025-05-20 |
Hall Ashley |
Chief Development Officer |
限制性股票授予 (RSU) |
225 |
- |
- |
225 |
| 2025-03-15 |
Stevens Raymond C |
Chief Executive Officer |
限制性股票授予 (RSU) |
826,890 |
$7.02 |
$5.8M |
826,890 |
| 2025-03-15 |
Hall Ashley |
Chief Development Officer |
限制性股票授予 (RSU) |
51,048 |
- |
- |
118,338 |
| 2025-03-15 |
Yoon Jun |
Chief Financial Officer |
限制性股票授予 (RSU) |
413,445 |
$7.02 |
$2.9M |
413,445 |
| 2025-03-15 |
Lin Xichen |
Chief Scientific Officer |
限制性股票授予 (RSU) |
80,829 |
- |
- |
166,536 |
| 2025-03-15 |
Ma Yingli |
Chief Technology Officer |
限制性股票授予 (RSU) |
63,810 |
- |
- |
100,539 |
| 2025-03-15 |
Coll Crespo Blas |
Chief Medical Officer |
限制性股票授予 (RSU) |
116,988 |
- |
- |
219,588 |
| 2025-03-01 |
Stevens Raymond C |
Chief Executive Officer |
RSU 预扣税 |
12,495 |
$7.92 |
$98.92K |
1,121,183 |
| 2025-03-01 |
Yoon Jun |
Chief Financial Officer |
RSU 预扣税 |
5,940 |
$7.92 |
$47.02K |
1,287,359 |
| 2025-03-01 |
Lin Xichen |
Chief Scientific Officer |
RSU 预扣税 |
6,441 |
$7.92 |
$50.99K |
160,095 |
| 2025-03-01 |
Ma Yingli |
Chief Technology Officer |
RSU 预扣税 |
1,824 |
$7.92 |
$14.44K |
98,715 |
| 2025-03-01 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 预扣税 |
1,233 |
$7.92 |
$9.76K |
218,355 |
| 2025-02-06 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
知情卖出 |
41 |
- |
- |
- |
| 2024-11-20 |
Yoon Jun |
Chief Financial Officer |
限制性股票授予 (RSU) |
821 |
- |
- |
2,115 |
| 2024-11-20 |
Coll Crespo Blas |
Chief Medical Officer |
限制性股票授予 (RSU) |
363 |
- |
- |
728 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
